内容摘要：Kelly Saxer, lead farmer at Agritopia, a community nestled around a plot of agricultural land, harvests lettuce April 22, 2025, in Gilbert, Ariz. (AP Photo/Annika Hammerschlag)

Kelly Saxer, lead farmer at Agritopia, a community nestled around a plot of agricultural land, harvests lettuce April 22, 2025, in Gilbert, Ariz. (AP Photo/Annika Hammerschlag)

GLP-1 receptor agonists are injections used to treat diabetes, and some are also approved to treat obesity. They work by mimicking hormones in the gut and the brain to regulate appetite and feelings of fullness. Theyand can produce side effects that include nausea and stomach pain.

In the study, researchers analyzed data from 43 U.S. health systems to compare two groups: people withand diabetes who took GLP-1 drugs and other people with the same conditions who took diabetes drugs like sitagliptin. The two groups were equal in size and matched for other characteristics.After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk of death from any cause compared to those who took the other type of diabetes drug. There were 2,501 new cases of obesity-related cancer in the GLP-1 group compared to 2,671 cases in the other group.

The effect was evident in women, but not statistically significant in men. The study couldn’t explain that difference, but Mavromatis noted that differences in blood drug concentration, weight loss, metabolism or hormones could be at play.The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

How can the U.S. solve its growing maternal mortality crisis? Health experts say one way is to look to other countries.

The U.S. has one of theMOGADISHU, Somalia (AP) — The cries of distressed children filled the ward for the severely malnourished. Among the patients was 1-year-old Maka’il Mohamed. Doctors pressed his chest in a desperate attempt to support his breathing.

His father brought him too late to a hospital in‘s capital, Mogadishu. The victim of complications related to malnutrition, the boy did not survive.

“Are you certain? Did he really die?” the father, Mohamed Ma’ow, asked a doctor, shocked.The death earlier this month at Banadir Hospital captured the agony of a growing number of Somalis who are unable to feed their children — and that of health workers who are seeing hundreds of millions of dollars in U.S. support